Article
ABCB1 and OPRM1 single-nucleotide polymorphisms collectively modulate chronic shoulder pain and dysfunction in South African breast cancer survivors.
Pharmacogenomics - 1 Jun 2022
Firfirey Firzana, September Alison V, Shamley Delva
Abstract excerpt
Background: Chronic shoulder pain/disability is a well-recognized side effect of treatment for breast cancer, with ∼40% of patients experiencing this, despite receiving pain management. To manage acute and chronic pain, several opioids are commonly prescribed. Pharmacogenomics have implicated genes within the opioid signaling pathway, including ABCB1 and OPRM1, to contribute to an individual's variable response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
